The Food Drugs Authority(FDA), the National Medicine Regulatory Agency(NMRA) has approved a herbal medicine for COVID-19 treatment.
The herbal medicine Cryptolepis Sanguinolenta known locally as Nibima has been approved for clinical trials in January 2021.
According to the FDA, researchers at the Kwame Nkrumah University of Science and Technology(KNUST) submitted a clinical trial application in September 2020 to assess the safety and efficacy of Cryptolepis sanguinolenta.
A statement from the FDA reads: ” The Food Drugs Authority(FDA), the National Medicine Regulatory Agency(NMRA) in Ghana has approved a herbal medicine, Cryptolepis Sanguinolenta locally known as Nibima for clinical trials in January 2021″.
The situation continues that “In search for treatment for ongoing COVID-19 pandemic, researchers from the School of Public Health at the Kwame Nkrumah University of Science and Technology(KNUST) submitted a clinical trial application in September 2020 to assess the safety and efficacy of Cryptolepis sanguinolenta as a potential treatment for COVID-19. This follows results from laboratory studies conducted by KNUST research team which points in the direction of possible clinical benefits.”
Read the full statement below
GOT AN EXCLUSIVE INFO?........SEND IT TO US
Call our Editor on 0209391902 or click here and inform us via Whatsapp. You could equally email your stories or articles to [email protected] and we'll surely put them online
, the National Medicine Regulatory Agency(NMRA) has approved a herbal medicine for COVID-19 treatment.){kind=link}